| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.21 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |